粪便DNA中联合SFRP1及SEPT9基因甲基化检测对#br#
老年性结直肠癌早期诊断的临床研究#br#

临床肿瘤学杂志 ›› 2018, Vol. 23 ›› Issue (1): 25-29.

粪便DNA中联合SFRP1及SEPT9基因甲基化检测对#br# 老年性结直肠癌早期诊断的临床研究#br#

430070武汉解放军武汉总医院干部病房二科

收稿日期:2017-08-23 修回日期:2017-11-18 出版日期:2018-01-30 发布日期:2018-06-28

Clinical study on early diagnosis of elderly colorectal cancer by methylation of SFRP1 and SEPT9 genes in stool DNA

The Second Cadre Ward， Wuhan General Hospital of Chinese Peopless Liberation Army，

Received:2017-08-23 Revised:2017-11-18 Online:2018-01-30 Published:2018-06-28

摘要/Abstract

摘要： 目的探讨粪便DNA中联合分泌型卷曲相关蛋白1（SFRP1）及胞裂蛋白9（SEPT9）基因甲基化检测对老年性结直肠癌（CRC）早期诊断的临床价值。方法选取我院从2016年1月至2016年9月确诊的35例年龄＞60岁CRC患者为研究组，选取同期35例＞60岁正常体检者为对照组。提取CRC患者和正常体检者粪便DNA，采用甲基化特异性PCR（MSP）技术分别检测SFRP1及SEPT9基因的甲基化状态；比较CRC患者单基因和联合双基因甲基化检出率的差异，以及CRC患者联合双基因甲基化检出率与对照组的差异；分析CRC患者SFRP1或SEPT9基因甲基化与临床病理特征（如年龄、性别、肿瘤位置）的关系。
结果 CRC患者粪便DNA中SFRP1及SEPT9基因甲基化检出率分别为45.71％（16／35）和51.43％（18／35），均显著高于对照组的8.57％（3／35）和14.29％（5／35），差异均有统计学意义（P＜0.01）；联合双基因检测结果显示， 82.86％（29／35）的CRC患者粪便DNA中至少存在一个基因的甲基化，显著高于单基因检出率（P＜001），亦高于对照组的17.14％（6／35），差异有统计学意义（P＜001）。CRC患者SFRP1或SEPT9基因甲基化与年龄、性别、肿瘤位置均无关（P＞0.05）。结论粪便DNA中联合SFRP1及SEPT9基因甲基化检测比单基因检测更加敏感，对老年性CRC早期诊断具有重要的应用价值。

关键词: 老年性结直肠癌, 粪便DNA, 分泌型卷曲相关蛋白1, 胞裂蛋白9, 甲基化检测, 早期诊断

Abstract: ObjectiveTo investigate the clinical value of detection of combined secreted frizzledrelated proteins 1 （SFRP1） and septin 9（SEPT9） gene methylation in stool DNA for early diagnosis of elderly colorectal cancer （CRC）.
MethodsThirtyfive patients with CRC who were aged over 60 years from January 2016 to September 2016 were inrolled in the study. At the same time， 35 normal people， who passed the physical examination and were aged over 60 years， were selected as the control group. DNA in the stool of CRC and normal subjects was extracted. Methylation specific PCR （MSP） technique was used to detect the methylation status of SFRP1 and SEPT9 genes respectively. The difference of detection rate of single gene and double gene methylation in CRC patients was compared， and the detection rate of combined double gene methylation in CRC patients was compared with that in normal control group. The correlation between the methylation of SFRP1 or SEPT9 gene in CRC patients and the clinicopathological parameters， such as age， sex， and tumor location， was analyzed.
ResultsThe detection rates of methylation of SFRP1 and SEPT9 genes in stool DNA of CRC patients were 45.71％（16／35） and 51.43％（18／35）， respectively， which were significantly higher than those in control group 857％（3／35） and 14.29％（5／35）， and the differences were statistically significant （P＜0.01）. There was at least one gene methylation in the stool DNA of 82.86％（29／35） CRC patients， which was significantly higher than the single gene detection rate （P＜0.01）， which was also higher than that of the control group 17.14％（6／35）， the difference was statistically significant （P＜0.01）. The methylation of SFRP1 or SEPT9 genes in CRC patients was not related to age， sex and tumor location （P＞0.05）.
ConclusionThe methylation test of SFRP1 and SEPT9 genes in stool DNA is more sensitive than single gene detection， which is of great value in the early diagnosis of elderly colorectal cancer.

Key words: Elderly colorectal cancer, Stool DNA, Secreted frizzledrelated proteins 1 （SFRP1）, Septin 9（SEPT 9）, Methylation detection, Early diagnosis

蔡克银, 徐梅华, 王晓. 粪便DNA中联合SFRP1及SEPT9基因甲基化检测对#br# 老年性结直肠癌早期诊断的临床研究#br#[J]. 临床肿瘤学杂志, 2018, 23(1): 25-29.

CAI Keyin, XU Meihua, WANG Xiao. . Clinical study on early diagnosis of elderly colorectal cancer by methylation of SFRP1 and SEPT9 genes in stool DNA[J]. Chinese Clinical Oncology, 2018, 23(1): 25-29.

参考文献

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed